Empagliflozin Impurity 130 CAS 289039-54-9

Purity >95%In StockPharmacopoeial Impurity Standards
CAS No.289039-54-9
Molecular FormulaC9H8ClIO2
Molecular Weight310.52 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Empagliflozin Impurity 130 CAS 289039-54-9 chemical structure

Description

CATO manufactures Empagliflozin Impurity 130 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Empagliflozin Impurity 130 (CAS 289039-54-9) is a certified pharmaceutical impurity reference standard with the molecular formula C9H8ClIO2 and a molecular weight of 310.52 g/mol.

Empagliflozin Impurity 130 (C9H8ClIO2) contains a carboxylic acid group, a hydroxyl group, an ether linkage, chlorine/iodine substitution, an aromatic ring system. Halogen substitution raises its density and boiling point, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

Physical & Chemical Properties

Molecular FormulaC9H8ClIO2
Molecular Weight310.52 g/mol
AppearanceOff-white to pale yellow crystalline powder. (slight halide-like odor, low volatility)
Purity>95%
StorageStore at room temperature
Solubility (reference)Soluble in methanol, acetonitrile, DMSO, water (slightly soluble)
StabilityMay oxidize slowly on prolonged air exposure; Contains ester bond; hydrolyzes under strong alkaline conditions
Degree of Unsaturation (DBE)5.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)2025
Halogen ContentCl/I-containing

Related Empagliflozin Standards

Recommended Standards

Why CATO?